期刊
ONCOTARGET
卷 8, 期 1, 页码 1884-1912出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.12242
关键词
CTCs; DTCs; metastases; EpCAM; MICs
资金
- Wilhelm-Sander-Stiftung [2015.019.1]
- Deutsche Forschungsgemeinschaft (DFG) [GI540-3/1]
- CANCER-ID, an Innovative Medicines Initiative Joint Undertaking [115749]
- European Union's Seventh Framework Program (FP7)
Enumeration of circulating tumor cells (CTCs) in peripheral blood with the gold standard CellSearch (TM) has proven prognostic value for tumor recurrence and progression of metastatic disease. Therefore, the further molecular characterization of isolated CTCs might have clinical relevance as liquid biopsy for therapeutic decision-making and to monitor disease progression. The direct analysis of systemic cancer appears particularly important in view of the known disparity in expression of therapeutic targets as well as epithelial-to-mesenchymal transition (EMT)-based heterogeneity between primary and systemic tumor cells, which all substantially complicate monitoring and therapeutic targeting at present. Since CTCs are the potential precursor cells of metastasis, their in-depth molecular profiling should also provide a useful resource for target discovery. The present review will discuss the use of systemically spread cancer cells as liquid biopsy and focus on potential target antigens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据